| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a6399d236ec0ea3dc12007c4c82740e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 |
| filingDate |
1977-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1985-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aec9f31603e2f4f7acc87f835737c67c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e0b2362f9049684a4bcb9f1f2d4e278 |
| publicationDate |
1985-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4529604-A |
| titleOfInvention |
N,N-Di-(n-Propyl)dopamine derivatives |
| abstract |
N,N-Di-(n-propyl)dopamine derivatives having peripheral dopamine receptor agonist activity prepared by synthetic routes known for phenethylamines. The renal vasodilator effect of 3,4-dihydroxy-N,N-di(n-propyl)-phenethylamine is potentiated by the concomitant administration of the beta -blocker propranolol. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5232923-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0418065-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5116979-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0399814-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5290793-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0333522-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0333522-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0418065-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0399814-A3 |
| priorityDate |
1977-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |